Clinical Guideline InSights
The 2026 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events Scientific Statement and the 2026 Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease Scientific Statement * Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease * American College of Cardiology * June 30, 2026 * Guideline Summary: https://www.guidelinecentral.com/guideline/5230408/ [https://www.guidelinecentral.com/guideline/5230408/] / https://www.guidelinecentral.com/guideline/5230407/ [https://www.guidelinecentral.com/guideline/5230407/] * Full-Text: https://www.jacc.org/doi/10.1016/j.jacc.2026.05.033 [https://www.jacc.org/doi/10.1016/j.jacc.2026.05.033] / https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037#tbl2 [https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037#tbl2]
57 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Clinical Guideline InSights-Community!